drugset / Trial / NCT01935700

Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma

NCT01935700

NaSingle-groupOpen-labelTreatment

Summary

This trial is to evaluate the potential of colchicine for the palliative management of hepatocellular carcinoma patients with distant metastasis or large vessel invasion using the Department of Health R.O.C. approved doses and methods of administration.

Timeline

Start
2013-06-06
Primary completion
2019-05-31
Completion
2019-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 1 mg Oral